MedTrace Logo

Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery

NCT01457586 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-10-24

No results posted yet for this study

Summary

Observational Study of Hemoderivative Transfusion Imputable Complications in Initial Uncomplicated Heart Surgery. Inclusion criteria are patients who discontinued the mechanical ventilation up to 6 hours after exiting operation room and who discontinued vasoactive drugs up to the beginning of the second postoperative day.

Blood transfusion might be only a marker of the patient severity.

Conditions

  • Heart Diseases

Interventions

BIOLOGICAL

Blood transfusion

Blood transfusion in perioperative period.

BIOLOGICAL

No blood transfusion

No transfusion in the perioperative period.

Sponsors & Collaborators

  • Hospital Pitangueiras

    lead OTHER

Principal Investigators

  • ROBERTO R Silva, MD PHD · Hospital Pitangueiras

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457586 on ClinicalTrials.gov